The press is quiet when it should be printing positive articles about Trius and Tedizolid. Why aren't they cheering for the latest pronouncements from the company?
Large positions will be filled and then the articles will follow. It's a dance and someone must lead.
They're waiting for all of the "bigs" to get their fill in the $8s first!